CenTrial Logo

A Clinical Trial Examines the Effects of Treating Insatiable Appetite with Setmelanotide


Clinical trial determines setmelanotide provides relief for Bardet-Biedle syndrome sufferers

Bardet-Biedl syndrome is a rare genetic disease that affects people of all ages. It is associated with hyperphagia, a condition where people experience an insatiable appetite, leading to early-onset, severe obesity. Unfortunately, there is limited information on how hyperphagia and obesity affect the quality of life in people with this condition. But, recent research has shown that treating the symptoms of Bardet-Biedl syndrome can significantly improve the quality of life of affected individuals.

A Phase 3 clinical trial evaluated the effectiveness of setmelanotide in improving the quality of life of patients with Bardet-Biedl syndrome. The trial included patients of all ages with Bardet-Biedl syndrome and obesity who received 52 weeks of setmelanotide treatment.

The patients then completed various self-reported health-related quality-of-life measures.

For patients aged under 18 years, caregivers completed the Pediatric Quality of Life Inventory (PedsQL), while adults aged 18 years and above completed the Impact of Weight on Quality of Life Questionnaire-Lite (IWQOL-Lite). The results showed that patients reported significant improvements in their quality of life after one year of setmelanotide treatment.

After 52 weeks of treatment with setmelanotide, children and teenagers with Bardet-Biedl syndrome experienced an average increase in PedsQL score of 11.2 points. All patients who had problems with their PedsQL score before treatment saw clinically significant improvement. In adults, the average increase in IWQOL-Lite score from baseline was 12.0 points, and 62.5% of adults who had problems with their IWQOL-Lite score before treatment also saw clinically significant improvement.

Are you interested in clinical trials near you?

You can receive free notification of a trial for this, or any other condition, by completing a short confidential health profile.
Find a clinical trial near me

The results also showed that the IWQOL-Lite score was significantly correlated with changes in percent body weight and body mass index. These findings demonstrate the importance of addressing impaired health-related quality of life in Bardet-Biedl syndrome and support the use of setmelanotide for reducing this burden.


This study provides hope for patients with Bardet-Biedl syndrome and their families, as it highlights the potential benefits of treating the symptoms of this rare genetic disorder. The study also underscores the need for more research on this condition and how to manage it effectively.

If you or someone you know has Bardet-Biedl syndrome and is struggling with hyperphagia and obesity, it's important to talk to your healthcare provider about treatment options, including setmelanotide. By working together, you can help improve the quality of life of individuals with Bardet-Biedl syndrome and reduce the burden of this rare genetic disease.

Share this article with a friend:

Get emailed clinical trial results in the categories of your choice:
Free subscription to clinical trial results

Signup to be notified of clinical trials near you that match your condition

Signup and be matched to trials near you
This free service will notify you of current and future clinical trial matches.

This content is for informational and educational purposes only. It is not intended to provide medical advice or to take the place of such advice or treatment from a personal physician. All readers/viewers of this content are advised to consult their doctors or qualified health professionals regarding specific health questions. CenTrial Data Ltd. does not take responsibility for possible health consequences of any person or persons reading or following the information in this educational content. Treatments and clinical trials mentioned may not be appropriate or available for all trial participants. Outcomes from treatments and clinical trials may vary from person to person. Consult with your doctor as to whether a clinical trial is a suitable option for your condition. Assistance from generative AI tools may have been used in writing this article.